
Becton, Dickinson and Company (NYSE: BDX), the global medical technology company, appointed Ellen Strahlman, M.D., M.H.Sc., Chief Medical Officer and Senior Vice President, Research & Development. Ellen had been SVP and Chief Medical Officer at GlaxoSmithKline. Read more in the prnewswire
press release.
Recent Comments